Don’t Let Data Blind Spots Undermine Your First Italian Sunshine Reporting Disclosure

Table of content

• What Does Sunshine Reporting Actually Involve?
• The Cross-Border Problem Many Companies Overlook
• A Structured Path to Compliance: Four Phases That Work
• A Practical Point Worth Noting: The Individual Reference Requirement
• Technology as an Enabler, Not a Magic Wand
• Ready to assess your organisation’s readiness for Italian Sunshine Reporting?

Italy’s Sunshine Reporting obligation, the national law requiring life sciences companies including pharmaceutical and medical device companies (human and animal health sector) to publicly disclose Transfers of Value (TOVs) to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs), is no longer a distant compliance horizon. For companies operating in Italy, the clock is ticking, and the complexity of getting it right the first time cannot be underestimated.

What Does Sunshine Reporting Actually Involve?

At its core, Italian Sunshine Reporting requires companies to collect, validate, and submit structured data on every payment or benefit provided to HCPs and HCOs, from speaker fees and advisory board payments to hospitality, travel, and research grants. This data must ultimately be submitted to the Ministry of Health in XML format, rather than simple spreadsheet reporting.

What makes the exercise genuinely difficult is not the concept, but the execution. Value transfers often originate from multiple systems: SAP for grants, a CRM like Salesforce for promotional activities and speaker engagements, Concur or similar platforms for travel and hospitality. Each system holds a piece of the puzzle, and pulling it all together into a single, accurate, reportable dataset requires both technical integration and organisational alignment.

The Cross-Border Problem Many Companies Overlook

One of the most common and costly blind spots in Italian Sunshine Reporting is cross-border transfers. Consider a scenario where a life science company’s global headquarters pays for an Italian HCP to attend an international advisory board, without ever notifying the Italian affiliate. From the country’s perspective, that transfer simply doesn’t exist, until a regulator asks about it.

Similarly, if a global congress held in Rome is sponsored by corporate headquarters rather than the Italian entity, but the payment flows to an Italian medical association, it becomes a reportable transfer of value in Italy. Such cross-border and head-office-funded activities can create reporting blind spots, especially where affiliates, intermediaries, and global functions do not share complete data.

A Structured Path to Compliance: Four Phases That Work

Based on experience supporting companies through first-time disclosures, a four-phase approach has proven consistently effective.

The first phase is about building the right internal team, not involving everyone, but identifying a handful of people who genuinely own and understand the data. Compliance, finance, legal, IT, marketing and medical affairs each play a role, but keeping the core group lean ensures decisions get made.

The second phase is a high-level inventory: mapping every function that generates Transfers Of Value (TOVs), identifying the data sources that support them, and surfacing overlaps or gaps. This is where surprises tend to emerge, occupational physicians, for example, are technically HCPs and may receive significant payments that fall entirely outside traditional tracking.

Phase three addresses gap analysis and remediation. If a system lacks a required data field, say, an HCP’s date of birth or tax code, there are both short-term workarounds (supplementary Excel tables, manual extraction) and longer-term system fixes. Getting this right before the first disclosure is critical, because errors in the XML file may create submission or compliance issues under the Ministry’s reporting framework.

The fourth phase is organisational readiness: training staff, updating internal policies, briefing foreign colleagues who interact with Italian HCPs, and even working with external travel agencies, which face their own challenges given high employee turnover. Equally important is communicating with doctors and institutions themselves, since they are increasingly aware that their names will appear in public disclosures.

A Practical Point Worth Noting: The Individual Reference Requirement

One area of ongoing industry debate is the Ministry’s requirement to associate a named physical person with grants made to legal entities, such as universities or hospitals. In practice, this means the department head who signed a research request may appear in the public register as the recipient of substantial funding, even though they personally received nothing.

Industry associations are actively challenging this interpretation, arguing it conflicts with anti-corruption principles and risks misleading the public. For now, companies must comply with the requirement as it stands, while staying alert to regulatory developments.

Technology as an Enabler, Not a Magic Wand

Compliance platforms that bring together all TOV data into a single monitored environment can dramatically reduce the burden of ongoing reporting. Real-time dashboards showing outliers within HCP categories, drill-down transaction views, and automated XML generation turn what is otherwise a labour-intensive manual process into something that can make the annual reporting cycle far more manageable.

But technology only delivers value if the underlying data is clean, complete, and consistently sourced, which is why the four phases above matter so much.

Ready to assess your organisation’s readiness for Italian Sunshine Reporting?

Whether you are preparing for your first disclosure or looking to streamline an existing process, you may realize the need to ask for a support in such new and complex project; choosing the right transparency reporting partner and getting ongoing expert advice can help you map your data landscape, close compliance gaps, and generate Ministry-compliant XML files with confidence.

→ Continue to  learn how you can cover everything from gap analysis to first Italian Sunshine report submission.

→ Already tracking your TOVs? Ask Italian Sunshine Reporting  about integrating your existing data into the right monitoring platform for seamless, ongoing compliance.

→ Not sure where to start? Explore our resources and blogs to understand what Italian Sunshine Reporting means specifically for your organisation.

Author

International Expert in Ethics, Compliance, and Transparency
Thought Leader in Reporting on the Italian Sunshine Act

Edoardo, a former MedTech compliance manager, has over 25 years of experience in compliance and transparency. A recognized opinion leader, Edoardo has led ethics programs at major pharmaceutical companies and offers strategic insights into compliance practices in Italy.